- Investing.com
Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, including supplier management, analytics, inventory management, and clinical supply management; and various programs to provide outsourced logistics and marketing solutions to its suppliers. The Patient Direct segment provides products and services for in-home care and delivery across diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment. This segment supplies a range of other home medical equipment, patient care products, including ostomy, wound care, urology, incontinence and other products and services. It serves multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians’ practices, and networks of hospitals directly, as well as indirectly through third-party distributors. Owens & Minor, Inc. was founded in 1882 and is headquartered in Mechanicsville, Virginia.
Strategic Expansion | Owens & Minor's $1.36B Rotech acquisition aims to boost presence in high-growth Patient Direct business, presenting opportunities and integration challenges |
Financial Flux | Recent CFO transition and Q2 2024 results surpassing expectations highlight Owens & Minor's evolving financial landscape and market's cautious stance |
Industry Dynamics | Explore how GLP-1 drugs and potential Chinese tariffs are reshaping the healthcare distribution sector, impacting Owens & Minor's market position |
Analyst Outlook | With price targets ranging from $18 to $23, analysts maintain a cautious view on Owens & Minor's growth strategy and integration efforts |
Metrics to compare | OMI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipOMIPeersSector | |
---|---|---|---|---|
P/E Ratio | −21.3x | 0.0x | −0.7x | |
PEG Ratio | −0.36 | −0.03 | 0.00 | |
Price/Book | 1.2x | 0.9x | 2.6x | |
Price / LTM Sales | 0.1x | 0.8x | 3.2x | |
Upside (Analyst Target) | 3.9% | 35.4% | 44.5% | |
Fair Value Upside | Unlock | 21.0% | 6.6% | Unlock |